Immunosuppressive Therapy for Heart Failure

Heart Failure Clinics

Volumn 1, Issue 3, 2005, Pages 449-456

  Wojnicz, Romuald ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIVIRUS AGENT; AUTOANTIBODY; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN A; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID; IMMUNOGLOBULIN; LOOP DIURETIC AGENT; PLACEBO; PREDNISONE; SPIRONOLACTONE; STEROID;

AGE DISTRIBUTION; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; DRUG EFFICACY; HEART FAILURE; HEART FUNCTION; HEART MUSCLE BIOPSY; HORMONAL THERAPY; HUMAN; IMMUNE RESPONSE; IMMUNOADSORPTION; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MYOCARDITIS; NONHUMAN; PATIENT SELECTION; REVIEW; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL; VIRUS INFECTION;

ANIMALS; CARDIOMYOPATHY, DILATED; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYOCARDITIS;

EID: 33645969583     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2005.06.009     Document Type: Review

References (65)

1. Woodruff J.F. Viral myocarditis: a review. Am J Pathol 101 (1980) 427-484
2. Bowles N.E., Richardson P.J., Olsen E.G.J., et al. Detection of coxackie-B virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1 (1986) 1120-1123
3. Klingel K., Hohenadl C., Canu A., et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A 89 (1992) 314-318
4. Huber S.A. Animal models of human disease: autoimmunity in myocarditis: relevance of animal models. Clin Immunol Immunopathol 83 (1997) 93-102
5. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death. Learning from the past for the future. Circulation 99 (1999) 1091-1100
6. Shreeniwas R., Koga S., Karakurum M., et al. Hypoxia mediated induction of endothelial cell interleukin-1 alpha: an autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest 90 (1992) 2333-2339
7. Xin-liang M., Lefer D.J., Lefer A.M., et al. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 86 (1992) 937-946
8. Birdsall H.H., Green D.M., Trial J., et al. Complement C5a, TGF-β1, and MCP-1, in sequence, induce migration of monocytes into ischemic myocardium within the first 1 to 5 hours following reperfusion. Circulation 95 (1997) 684-692
9. Garlichs C.D., John S., Schmeiber A., et al. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 104 (2001) 2395-2400
10. Devaux B., Scholz D., Hirche A., et al. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J 19 (1997) 470-479
11. Hasper D., Hummel M., Kleber F.X., et al. Systemic inflammation in patients with heart failure. Eur Heart J 19 (1998) 761-765
12. Cetta F., and Michels V.V. The autoimmune basis of dilated cardiomyopathy. Ann Med 27 (1995) 169-173
13. Aukrust P., Ueland T., Lien E., et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83 (1999) 376-382
14. Klappacher G., Mehrabi M., Franzen P., et al. Endomyocardial HLA expression is increased to the same extent in idiopathic and secondary dilated cardiomyopathy. Immunol Lett 41 (1994) 59-66
15. Druet P. Diagnosis of autoimmune diseases. J Immunol Methods 150 (1992) 177-184
16. Aretz H.T. Myocarditis: the Dallas criteria. Hum Pathol 18 (1987) 619-624
17. Herskowitz A., Ahmed-Ansari A., Neumann D.A., et al. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll Cardiol 15 (1990) 624-632
18. Chan K.Y., Iwahara M., Benson L.N., et al. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. J Am Coll Cardiol 17 (1991) 458-460
19. Jones S.R., Herskowitz A., Hutchins G.M., et al. Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function. Am J Cardiol 68 (1991) 370-376
20. Maisch B., Schonian U., Hengstenberg C., et al. Immunosuppressive treatment in autoreactive myocarditis: results from a controlled trial. Postgrad Med J 70 (1994) 29-34
21. Kuhl U., and Schultheiss H.P. Treatment of chronic myocarditis with corticosteroids. Eur Heart J 16 (1995) 168-172
22. Cooper L.T., Berry G.J., Shabetai R., and for the Multicenter Giant Cell Myocarditis Study Group Investigators. Idiopathic giant-cell myocarditis: natural history and treatment. N Engl J Med 336 (1997) 1860-1866
23. Wojnicz R., Nowalany-Kozielska E., Wojciechowska C., et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104 (2001) 39-45
24. Fenoglio J.J., Ursell P.C., Kellog C.F., et al. Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med 308 (1983) 12-18
25. Parrillo J.E., Cunnion R.E., Epstein S.E., et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 321 (1989) 1061-1068
26. Mason J.W., O'Connell J.B., Herskowitz A., et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 333 (1995) 269-275
27. Figulla H.R., Rahlf G., Nieger M., et al. Spontaneous hemodynamic improvement of stabilization and associated biopsy findings in patients with congestive cardiomyopathy. Circulation 71 (1985) 1095-1104
28. O'Connell J.B. The role of myocarditis in end-stage dilated cardiomyopathy. Tex Heart Inst J 14 (1987) 268-275
29. Bach J.F. Immunosuppressive therapy of autoimmune diseases. Immunol Today 14 (1993) 322-326
30. Dickler H.B., and Albright J.F. Immunosuppression in the treatment of disease. J Allergy Clin Immunol 93 (1994) 669-676
31. Ullian M.E. The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res 41 (1999) 55-64
32. Skyschally A., Haude M., Dorge H., et al. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization. Circulation 109 (2004) 2337-2342
33. Wilder R.L., Cupps T.R., and Balow J.E. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 119 (1993) 1198-1208
34. Kilbourne E.D., Wilson C.B., and Perrier D. The induction of gross myocardial lesions by a coxsackie (pleurodynia) virus and cortisone. J Clin Invest 35 (1956) 362-370
35. Kawai C., and Takatsu T. Clinical and experimental studies on cardiomyopathy. N Engl J Med 293 (1975) 592-597
36. Tomioka N., Kishimoto C., Matsumori A., et al. Effects of prednisone on acute viral myocarditis in mice. J Am Coll Cardiol 7 (1986) 868-872
37. O'Connell J.B., Reap E.A., and Robinson J.A. The effects of cyclosporine on acute murine coxsackievirus B3 myocarditis. Circulation 73 (1986) 353-359
38. Monrad S.C., Matsumori A., Murphy J.C., et al. Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus. Circulation 73 (1986) 1058-1064
39. Rezkalla S., Khatib R., Khatib G., et al. Effects of indomethacin in the late phase of coxsackievirus myocarditis in a murine model. J Lab Clin Med 112 (1988) 118-121
40. Mason J.W., Bilingham M.E., and Ricci D.R. Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol 45 (1980) 1037-1044
41. Garrison R.F., and Swisher R.C. Myocarditis of unknown etiology (Fiedler's) treated with ACTH: report of a case in a 7-year-old boy with improvement. J Pediatr 42 (1953) 591-599
42. Ainger L.E. Acute aseptic myocarditis: corticosteroid therapy. J Pediatr 64 (1964) 716-723
43. Weetman A.P., McGregor A.M., Ludgate M., et al. Cyclosporin improves Graves, ophthalmopathy. Lancet 2 (1983) 486-489
44. Brabant G., Peter H., Becker H., et al. Cyclosporine in infiltrative eye disease. Lancet 2 (1984) 515-516
45. Howlett T.A., Lawton N.F., and Ffils P. Deterioration of severe Graves' ophthalmopathy during cyclosporine treatment. Lancet 2 (1984) 1101
46. Gokel J.M., Reichart B., and Struck E. Human cardiac transplantation: evaluation of morphological changes in serial endomyocardial biopsies. Path Res Pract 178 (1985) 354-364
47. Sayegh M.H., and Turka L.A. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 338 (1998) 1813-1821
48. Kuhl U., Strauer B.E., and Schultheiss H.P. Methylprednisolone in chronic myocarditis. Postgrad Med J 70 (1994) 35-42
49. Frustaci A., Chimenti C., Calabrese F., et al. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responder versus nonresponders. Circulation 107 (2003) 857-863
50. McNamara D.M., Holubkov R., Starling R.C., et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103 (2001) 2254-2259
51. Gullestad L., Aass H., Fjeld J.G., et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 103 (2001) 220-225
52. Maisch B., Bauer E., Hufnagel G., et al. The use of endomyocardial biopsy in heart failure. Eur Heart J 9 (1988) 59-71
53. Chow L.C., Dittrich H.C., and Shabetai R. Endomyocardial biopsy in patients with unexplained congestive heart failure. Ann Intern Med 109 (1988) 535-539
54. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. Circulation 104 (2001) 2996-3007
55. Hammond E.H., Menlove R.L., and Anderson J.L. Predictive value of immunofluorescence and electron microscopic evaluation of endomyocardial biopsies in the diagnosis and prognosis of myocarditis and idiopathic dilated cardiomyopathy. Am Heart J 114 (1987) 1055-1065
56. Nousias M., Seeberg B., Schultheiss H.P., et al. Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99 (1999) 2124-2131
57. Zee-Cheng C.S., Tsai C.C., Palmer D.C., et al. High incidence of myocarditis by endomyocardial biopsy in patients with idiopathic congestive cardiomyopathy. J Am Coll Cardiol 3 (1984) 63-70
58. Steenbergen C., Kolbeck P.C., Wolfe J.A., et al. Detection of lymphocytes in endomyocardium using immunohistochemical techniques: relevance to evaluation of endomyocardial biopsies in suspected cases of lymphocytic myocarditis. J Appl Cardiol 1 (1986) 63-73
59. Kolbeck P.C., Steenbergen C., Wolfe J.A., et al. The correlation of mononuclear cell phenotype in endomyocardial biopsies with clinical history and cardiac dysfunction. Am J Clin Pathol 9 (1989) 37-44
60. Kühl U., Seeberg B., Schultheiss H.P., et al. Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy. Eur Heart J 15 (1994) 62-67
61. Badorff C., Noutsias M., Kuhl U., et al. Cell-mediated cytotoxicity in hearts with dilated cardiomyopathy: correlation with interstitial fibrosis and foci of activated T lymphocytes. J Am Coll Cardiol 29 (1997) 429-434
62. Ansami A.A., Yi-Chong W., Danser D.J., et al. Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy. Am J Pathol 139 (1991) 337-354
63. Toyozaki T., Saito T., Takano H., et al. Expression of intercellular adhesion molecule-1 on cardiac myocytes for myocarditis before and during immunosuppressive therapy. Am J Cardiol 72 (1993) 441-444
64. Wojnicz R., Nowalany-Kozielska E., Wodniecki J., et al. Immunohistological diagnosis of myocarditis: potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury. Eur Heart J 19 (1998) 1564-1572
65. Nowalany-Kozielska E., and Wojnicz R. Immunosuppressive therapy for heart failure: a guide to patient selection. Am J Cardiovasc Drugs 3 (2003) 321-324